Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489226 · ClinicalTrials.gov registry record · NA
Capsimax Effect on Metabolic Rate, Satiety and Food Intake
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03489226 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 24 participants.
The verdict
NCT03489226, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Comparison of Capsimax™ 2mg and 4mg of capsicum extract vs. placebo on metabolic rate and satiety.
Interventions
- DIETARY_SUPPLEMENT Placebo
- OTHER Meal
- DIETARY_SUPPLEMENT Capsimax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-05-02 |
| Est. Completion | 2017-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03489226
The ClinicalTrials.gov registry entry for NCT03489226 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03489226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03489226 about?
NCT03489226 is a clinical study titled "Capsimax Effect on Metabolic Rate, Satiety and Food Intake". Comparison of Capsimax™ 2mg and 4mg of capsicum extract vs. placebo on metabolic rate and satiety.
What is the current status of trial NCT03489226?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-05-02. Estimated completion is 2017-07-12.
What interventions are being tested in trial NCT03489226?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Meal (OTHER), Capsimax (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03489226?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.